ATE463244T1 - Ophthalmische zusammensetzungen und verfahren zu deren verwendung - Google Patents

Ophthalmische zusammensetzungen und verfahren zu deren verwendung

Info

Publication number
ATE463244T1
ATE463244T1 AT05820879T AT05820879T ATE463244T1 AT E463244 T1 ATE463244 T1 AT E463244T1 AT 05820879 T AT05820879 T AT 05820879T AT 05820879 T AT05820879 T AT 05820879T AT E463244 T1 ATE463244 T1 AT E463244T1
Authority
AT
Austria
Prior art keywords
methods
ophthalmic compositions
compositions
ketotifen
concentration
Prior art date
Application number
AT05820879T
Other languages
English (en)
Inventor
Kenneth Green
George Minno
Susan Caballa
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/972,571 external-priority patent/US20060089384A1/en
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Application granted granted Critical
Publication of ATE463244T1 publication Critical patent/ATE463244T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05820879T 2004-10-25 2005-10-24 Ophthalmische zusammensetzungen und verfahren zu deren verwendung ATE463244T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/972,571 US20060089384A1 (en) 2004-10-25 2004-10-25 Ophthalmic compositions and methods of using the same
US62375804P 2004-10-29 2004-10-29
PCT/US2005/038186 WO2006047418A1 (en) 2004-10-25 2005-10-24 Ophthalmic compositions and methods of using the same

Publications (1)

Publication Number Publication Date
ATE463244T1 true ATE463244T1 (de) 2010-04-15

Family

ID=36228119

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05820879T ATE463244T1 (de) 2004-10-25 2005-10-24 Ophthalmische zusammensetzungen und verfahren zu deren verwendung

Country Status (13)

Country Link
US (2) US20060148899A1 (de)
EP (1) EP1845983B1 (de)
JP (1) JP4980226B2 (de)
KR (1) KR101252310B1 (de)
CN (1) CN101087607B (de)
AT (1) ATE463244T1 (de)
AU (1) AU2005299696B2 (de)
BR (1) BRPI0517451A (de)
CA (1) CA2585266C (de)
DE (1) DE602005020513D1 (de)
ES (1) ES2341789T3 (de)
MX (1) MX2007004905A (de)
WO (1) WO2006047418A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
US20090005362A1 (en) * 2007-06-26 2009-01-01 Vo Toan P Compositions Comprising Antihistamines or Mast Cell Stabilizers, and Methods of Making and Using Same
WO2009074853A2 (en) * 2007-12-10 2009-06-18 Promed Research Centre Ophthalmic composition comprising phenylephrine
US20100087550A1 (en) 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
WO2010047681A1 (en) * 2008-10-24 2010-04-29 Bridge Pharma, Inc. Treating xerophthalmia with norketotifen
WO2010059894A1 (en) * 2008-11-21 2010-05-27 Bridge Pharma, Inc. Ocular formulations of norketotifen
CA2754996A1 (en) * 2009-03-17 2010-09-23 Aciex Therapeutics, Inc. Ophthalmic formulations of ketotifen and methods of use
JP7014508B2 (ja) 2016-08-08 2022-02-01 シャープ株式会社 自律走行装置及び自律走行制御方法と制御プログラム
CA3209420A1 (en) 2021-02-24 2022-09-01 Peter Jarrett Intracanalicular depot inserter device
CA3264067A1 (en) 2022-08-04 2024-02-08 Bausch + Lomb Ireland Limited OPHTHALMIC COMPOSITION COMPRISING PILOCARPINE AND A REDNESS-REDUCING AGENT
WO2024028815A1 (en) 2022-08-04 2024-02-08 Bausch + Lomb Ireland Limited Ophthalmic composition comprising an anti-allergen and a redness reduction agent

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH656884A5 (de) * 1983-08-26 1986-07-31 Sandoz Ag Polyolester, deren herstellung und verwendung.
US4826871A (en) * 1985-03-13 1989-05-02 Gressel Philip D Topical ophthalmic compositions containing one or more retinoids
JPS62277323A (ja) * 1986-02-19 1987-12-02 Sankyo Co Ltd フマル酸ケトチフエン含有点眼液の製法
US5756450A (en) * 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
US5019591A (en) * 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
EP0938896A1 (de) * 1998-01-15 1999-09-01 Novartis AG In Autoklaven behandelbare pharmazeutische Zusammensetzungen mit Komplexbildner
JP2002510627A (ja) * 1998-04-02 2002-04-09 ノバルティス アクチエンゲゼルシャフト 抗酸化剤の特別な使用により医薬組成物を安定化するための方法
US6274626B1 (en) * 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
US6174859B1 (en) * 1999-04-06 2001-01-16 J & D Sciences, Inc. Method of treatment
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6777429B1 (en) * 1999-07-23 2004-08-17 Novartis Ag Ophthalmic composition
MXPA02005007A (es) * 1999-11-18 2004-08-12 Alcon Inc Uso de un antagonista h1 y un esteroide inocuo para tratar condiciones oculares.
US20040097486A1 (en) * 1999-11-18 2004-05-20 Yanni John M. Use of an H1 antagonist and a safe steroid to treat eye conditions
US6395756B2 (en) * 1999-12-23 2002-05-28 Novartis Ag Use of ophthalmic agent
US6531128B1 (en) * 2000-02-08 2003-03-11 Pharmacia Corporation Methods for treating glaucoma
JP3450805B2 (ja) * 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
US6515006B2 (en) * 2000-11-08 2003-02-04 Hmt Pharma, Inc. Ophthalmic formulation which modulates dilation
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
US20040198828A1 (en) * 2003-01-17 2004-10-07 Abelson Mark B. Combinational use of long-acting and short-acting anti-histamines for ocular allergies

Also Published As

Publication number Publication date
WO2006047418A1 (en) 2006-05-04
MX2007004905A (es) 2007-10-15
AU2005299696B2 (en) 2012-01-12
JP4980226B2 (ja) 2012-07-18
HK1110207A1 (en) 2008-07-11
CA2585266C (en) 2010-10-19
AU2005299696A1 (en) 2006-05-04
CN101087607A (zh) 2007-12-12
EP1845983B1 (de) 2010-04-07
EP1845983A1 (de) 2007-10-24
JP2008517937A (ja) 2008-05-29
KR20070074635A (ko) 2007-07-12
DE602005020513D1 (de) 2010-05-20
CN101087607B (zh) 2010-07-28
EP1845983A4 (de) 2008-03-12
US20060148899A1 (en) 2006-07-06
ES2341789T3 (es) 2010-06-28
KR101252310B1 (ko) 2013-04-08
BRPI0517451A (pt) 2008-10-07
US20120004265A1 (en) 2012-01-05
CA2585266A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
ATE494893T1 (de) Sulfonamide, sulfamate und sulfamide als gamma- secretase-hemmer
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE602005023763D1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
DE602005020611D1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
ATE463244T1 (de) Ophthalmische zusammensetzungen und verfahren zu deren verwendung
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
ATE368031T1 (de) Neue gamma secretase inhibitoren
NO20062860L (no) Sammensetning og fremgangsmate for styrking av biologisk tilgjengelighet
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
AR057631A1 (es) Composiciones y metodos para incrementar la sensibilidad a insulina
DE69833971D1 (de) Verfahren zur behandlung von alzheimerschen krankheit
EA201070148A1 (ru) Соединения и способы модулирования фарнезоидного рецептора x (fxr)
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
DE60126947D1 (de) Behandlung der glykogenspeicherkrankheit typ ii
PE20060500A1 (es) Derivados de heteroaril sulfamida benzo-fusionada como anticonvulsivantes
EA200601223A1 (ru) Производные сульфонамида для лечения заболеваний
DE602004012578D1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
CY1109763T1 (el) Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης
PE20060736A1 (es) DERIVADOS DE PIRROL COMO ANTAGONISTAS DE CRTh2
DE60326548D1 (de) Verfahren zur verhütung oder behandlung von herzarrhythmie
ATE460166T1 (de) Chinazolinderivate und ihre verwendung bei der behandlung von thrombocythämie
EA200601889A1 (ru) Лечение инфекционных заболеваний
ATE556053T1 (de) Piperidinderivate zur behandlung von alzheimer- krankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties